United States

Despite advances in information extraction driven by deep learning and large language models, performance gaps remain in highly specialized biomedical fields, where domain-specific complexity poses challenges for generalist models.
 In this work, we focus on the domain of autoimmunity where the main entities of interest are autoimmune diseases, autoantibodies (i.e. molecules that may mark or cause these diseases), their molecular targets, their location in the body, and the associated clinical signs. 
 Herein, we present AAbAAC (AutoAntibodies and Autoimmunity Annotated Corpus), a corpus of 115 abstracts selected from PubMed that we manually annotated for those entities and their relationships. 
 First, AAbAAC was used to evaluate several methods on the task of named entity recognition (NER), and second, to fine-tune NER models. 
 Our study demonstrates the utility of AAbAAC for information extraction in the domain of autoimmunity, showing expected improvement in NER performance after fine-tuning. This illustrates the value of small-scale annotation efforts for specialized domains and contributes to the computational study of autoimmunity. The AAbAAC corpus is available at: https://github.com/f-maury/AAbAAC .

ACL 2026

AAbAAC: An Annotated Corpus for Autoimmunity Information Extraction

autoantibodies

autoimmune diseases

annotated corpus

autoimmunity

relation extraction

named entity recognition

annotation

information extraction

**Welcome to ACL-IJCNLP 2021!**

The great event is jointly organized by the Association for Computational Linguistics (ACL) and Asian Federation of Natural Language Processing (AFNLP). 

As in previous years, the program of the conference includes a poster session, tutorials, workshops and demonstrations in addition to the main conference.


We were able to keep the registration fees similar to those charged for the virtual ACL 2020. The one fee allows attendance at the main conference and any/all tutorials and workshops. These fees would be $125 Regular Early and $175 Regular Late; $50 Student Early and $75 Student Late. Early registration closes at midnight July 11, 2021 (Eastern Daylight Time).

**Reminder:** It is ACL’s policy that at least one author of each accepted paper (including ACL Finding papers) must register for the conference.

**Reminder2:** Underline site will open closer to the event. If you already registered you will receive access detail

Registration is now open

ACL-IJCNLP 2021

The great event is jointly organized by the Association for Computational Linguistics (ACL) and Asian Federation of Natural Language Processing (AFNLP).

workshop paper

It is my great pleasure and honor to welcome you to the 64th Annual Meeting of the Association for Computational Linguistics (ACL 2026), held in San Diego, California, USA, July 2–7, 2026. ACL 2026 continues our fields tradition of excellence in scholarship, innovation, and inclusivity, and I am deeply grateful to the many volunteers who have worked tirelessly to bring this event to life.

It is exciting to see the many developments in the field reflected at our conference, such as the advancement of large language models (born out of our community) into many application directions. This is not without challenges, partly due to unsolved problems, and partly due to misuse of the technology. All this is reflected well at ACL 2026. The conference also reflects that the field is not only about advancing technology, but also the science of fundamentally understanding language and how it is use by many different speaker communities. <br>
[Full Message from General Chair Philipp Koehn](https://drive.google.com/file/d/1QiJFOmMjvDgsDo3i1XzlQnImxe3RU_Cy/view?usp=sharing) <br><br><br>
<html><button style="display: inline-flex; align-items: center; justify-content: center; white-space: nowrap; border-radius: 9999px; font-weight: bold; background: #7c3aed; color: white; font-family: 'Space Grotesk', sans-serif; height: 40px; font-size: 16px; padding: 0 20px; border: none; cursor: pointer" onclick="window.open('https://drive.google.com/file/d/1QiJFOmMjvDgsDo3i1XzlQnImxe3RU_Cy/view?usp=sharing')">Conference Handbook</button></html>
<br><br><br><br>

To access this event page, you need to log in with the **email address you registered with**. <br>Access credentials will be sent to your email from Underline -  subject line "Welcome to ACL 2026". Please be sure to check your spam email folder if you do not see an email confirmation right away.

To access this event page, you are required to register.
Please complete your registration to continue.

We recommend reading [**the registration information**](https://2026.aclweb.org/registration/) first.

Registration Required

The 64th Annual Meeting of the Association for Computational Linguistics (ACL 2026) will take place in San Diego, California, from July 2 - 7, 2026.

Biomedical named entity recognition (NER) and entity linking (EL) strongly depend on annotated corpora, but the utility of these resources for benchmarking is often assumed rather than characterized. We present a corpus-centric framework for diagnosing benchmark-relevant properties directly from corpus annotations, concept links, train-test splits, document metadata, and terminology mappings. The framework organizes standardized statistics into five families: (1) scale, density and label distribution, (2) lexical and conceptual structure, (3) train-test overlap, (4) metadata composition, and (5) terminology coverage where applicable. Applying the framework to nine corpora spanning diseases, chemicals, and cell types, we find that corpus properties can differ substantially, even when they address the same apparent task. We find differences in the evaluation signal they provide, the generalization demands they impose, the degree of train–test reuse they permit, and the regions of biomedical literature and concept space they represent. These differences suggest that commonly reported corpus statistics can be insufficient to characterize what biomedical NER and EL benchmarks evaluate. We argue that corpus-centric diagnostics provide a practical framework for analyzing corpora beyond surface descriptors such as corpus size and entity type, for identifying potential transfer risks, and for interpreting the scope of benchmarking conclusions. We release the framework as open-source code with an interactive dashboard to support reproducing our analyses and characterizing additional corpora.

What Do Biomedical NER and Entity Linking Benchmarks Measure? A Corpus-Intrinsic Diagnostic Framework

Systematic reviews underpin evidence-based medicine but can outdate quickly when new evidence appears. We formulate a novel prediction task: given a review and new studies that have appeared since its publication, predict whether the review's conclusions will change. A dataset of 3,326 Cochrane review-update pairs is constructed and a range of approaches explored including feature-based baselines, zero and few-shot LLMs, in addition to parameter efficient fine-tuning. Fine-tuning Qwen2.5
 14B achieves the highest AUC-ROC (70.4%).

Can NLP Models Detect When One Publication Outweighs Twenty? Predicting Systematic Review Conclusion Changes

Systematic reviews are fundamental to evidence-based medicine, but the clinical evidence they contain is primarily expressed in unstructured text, making large-scale extraction and reuse difficult. Existing biomedical NLP methods have achieved strong performance on span-level extraction from clinical trials and abstracts; however, these approaches are insufficient for systematic reviews, where evidence is often distributed across multiple studies, sentences, and sections and must be aggregated into normalized document-level attributes. We introduce VaxScope, a benchmark dataset for document-level structured evidence extraction from immunization-related systematic reviews. VaxScope is constructed through an expert-guided semi-automatic annotation pipeline that combines automatic candidate generation with domain expert validation to ensure consistency and annotation quality. We formalize the task as document-level structured extraction, where target labels are defined at the review level and require aggregating evidence beyond isolated textual spans. We further establish baselines for document-level structured extraction using abstract-level input representations and evaluate how access to evidence-grounded contextual input improves performance over abstract-only settings. Baseline experiments show that PubMedBERT achieves the best overall performance (Avg F1: 0.850), with evidence-grounded input improving performance particularly for fields requiring distributed contextual reasoning.

VaxScope: Document-Level Structured Evidence Extraction from Immunization Systematic Reviews

The exponential growth of biomedical literature has made manual curation of biological interaction networks increasingly difficult. Existing automated biological interaction extraction systems address the scaling challenge but treat extraction as a final step, delivering structured output with limited or no integrated support for biologists to interactively verify, correct and contextually interrogate extracted interactions against their source evidence within the same environment. We present Knowledge-Assisted Literature Mining for Biological Interaction Analysis (KALIMBA), an end-to-end, human-in-the-loop platform that integrates three complementary extraction methods (NLP-only, LLM-only, and hybrid) alongside expert annotation and evidence-grounded conversational querying through retrieval-augmented generation (RAG) chat module driven by a dual-context prompt, within a single unified workflow. Evaluation on a corpus of 40 signaling-focused papers demonstrates that the LLM-only back-end recovers substantially more interactions than the NLP-only approach. RAG chat evaluation by a domain expert confirms that the conversational module provides scientifically grounded responses that support curation decisions beyond what the structured interaction table alone conveys.

KALIMBA: Knowledge-Assisted Literature Mining for Biological Interaction Analysis

Medical question answering is a high-stakes setting where factual errors can have serious consequences. Retrieval-augmented generation (RAG) is widely viewed as a promising solution, and prior work has reported substantial gains for large medical QA models. We revisit this assumption across a broad range of open-weight instruction-tuned models spanning 7B to 72B parameters. Across five models, ten biomedical QA datasets, four retrieval methods, and four retrieval corpora, we find that retrieval yields only small and inconsistent improvements over a no-retrieval baseline, typically within 1--2 points. In contrast, the choice of backbone model has a much larger effect than the choice of retriever or corpus, and expert and layman retrieval sources perform similarly in most settings. These results suggest that the main bottleneck is not retrieval quality alone, but the model's limited ability to use retrieved evidence effectively.

When Retrieval Doesn't Help: A Large-Scale Study of Biomedical RAG

Visual-language models (VLMs) are rapidly advancing on tasks that require visual understanding of text, tables, plots, and diagrams. Yet extracting structured information from text-heavy scientific diagrams remains challenging, as it requires not only OCR but also recovery of layout, grouping, and flow relationships. We study this problem in the context of CONSORT flow diagrams, which summarize participant screening, randomization, follow-up, and analysis in randomized controlled trials. We introduce a 200-example benchmark of PubMed Central diagrams, annotated by a biomedical team specializing in systematic literature reviews and clinical evidence extraction, and evaluate schema-constrained CONSORT extraction across proprietary and open-weight model families. Using structure-aware metrics, we compare single-pass and stepwise extraction strategies. Expert-guided single-pass extraction performs best for proprietary frontier models, with Gemini 3 Pro achieving the strongest overall results, whereas stepwise prompting improves less capable open-weight models on challenging arm-level extraction. These results offer practical deployment guidance and suggest that high-quality schema-constrained extraction is feasible, but not yet solved.

Diagnosis: Bad Planning & Reasoning. Treatment: SCoPE - Planning for Hybrid Querying over Clinical Trial Data

Tabular data is widely used in important areas such as healthcare and finance, but building accurate models in real-world settings faces three main challenges: protecting data privacy, handling distributed data, and maintaining strong performance. Existing methods do not solve these issues together. Converting tabular data into text for Large Language Models (LLMs) can expose sensitive information, struggle with anonymized features and exact numerical values, and require expensive training while often not outperforming traditional tree-based models. In addition, many real-world datasets are spread across different institutions, making centralized training impossible. We propose a federated framework that connects distributed tabular data with LLM reasoning using decision tree rules as privacy-preserving intermediaries. Each client trains a local Random Forest and shares only extracted rules—feature comparisons and thresholds, without revealing raw data. These rules are combined into a global pool, allowing an LLM to generate a better partitioning rule without accessing any original data, adding an extra layer of privacy. Using this rule, each client learns local gradient-based corrections, which are then aggregated. We also show that this process reduces prediction error. Experiments on 12 datasets, including seven medical tasks, show that our method consistently outperforms federated baselines and achieves results close to centralized models.

Expert-Guided Schema-Based Structured Extraction from CONSORT Diagrams Using Vision-Language Models

The rapid expansion of biomedical literature makes manual identification of novel drug-disease relationships increasingly difficult. Existing approaches have leveraged LLMs to mine abstracts or construct knowledge graphs for drug repurposing. There are two key limitations: finite context windows for capturing macro-level research trends, and single-pass black-box pipelines make it difficult to verify outputs. This paper proposes a pipeline for discovering new drug targets by combining disease and drug research trends using Large Language Models (LLMs). Our method extracts PICO components from PubMed abstracts, normalizing the Population and Intervention Component to ICD and ATC codes, respectively. A temporal frequency delta matrix is constructed to capture publication count shifts across 2013 to 2022, then used to discover novel drug areas. Compared with the abstract-based baseline, our approach showed qualitative signs of generating combinations that were more closely aligned with observed research trends and, in some cases, more clinically plausible. These findings suggest the potential usefulness of structured trend information for LLM-based exploration, although the differences between the two methods were limited and the results remain preliminary. Future work will focus on validating the consistency and reliability of these candidates.

Fast, Accurate, and Local Conversion of MIMIC-IV to OMOP with DBT

Family health history (FHx) offers insight into a person's health and disease risk, but it is largely held within free-text clinical formats that require processing for maximal utility of the data. The rapid deployment of ambient AI scribes and conversational agents in clinical settings necessitates evaluation on dynamic patient-clinician and patient-agent dialogs. To address this gap, we introduce two new datasets of patient FHx dialog documents designed to benchmark information extraction and entity linking. Distinct from clinician-entered datasets, patient-reported dialog data has its own semantic and content characteristics, which need to be studied for more patient-centered healthcare. We contribute a publicly available resource called FHexchange, with new annotations for family members, clinical observations, related entities, and standardized UMLS CUIs, offering the clinical NLP community a robust evaluation bed for emerging generative AI tools.

Exploring Novel Drug Research Area using Large Language Models Based on Research Trends in Biomedical Literature

We present IndicMedDialog, a parallel multi-turn medical dialogue dataset spanning English and nine Indic languages (Assamese, Bengali, Gujarati, Hindi, Marathi, Punjabi, Tamil, Telugu, and Urdu). The dataset extends the MDDial corpus with LLM-generated synthetic consultations, translated using TranslateGemma, verified by native speakers, and refined through a script-aware post-processing pipeline to correct phonetic, lexical, and character-spacing errors introduced during automatic translation. Building on this dataset, we fine-tune IndicMedLM via parameter-efficient adaptation (LoRA) of a quantized small language model, incorporating an optional patient pre-context to personalise multi-turn symptom elicitation. We evaluate IndicMedLM against zero-shot multilingual baselines across ten languages and conduct systematic error analysis, identifying five failure modes: Instruction Drift, Label Collapse, Cross-Domain Confusion, Tokenization Failure, and Paraphrase-over-Label Generation. Results show strong post-processed diagnostic accuracy in Hindi, Marathi, and Bengali, while Assamese, Tamil, and Telugu remain in an extreme failure tier attributable to base-model tokenizer gaps, a finding with direct patient safety implications. Medical expert evaluation confirms the clinical plausibility and safety of the generated consultations.

Content not yet available

Downloads

Next from ACL 2026

What Do Biomedical NER and Entity Linking Benchmarks Measure? A Corpus-Intrinsic Diagnostic Framework

Similar lecture

Information Extraction #2

Stay up to date with the latest Underline news!

PRESENTATIONS

CONFERENCES

COMPANY

RESOURCES

Content not yet available

.css-70qvj9{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;}Downloads

Next from ACL 2026

What Do Biomedical NER and Entity Linking Benchmarks Measure? A Corpus-Intrinsic Diagnostic Framework

Similar lecture

Information Extraction #2

Stay up to date with the latest Underline news!

PRESENTATIONS

CONFERENCES

COMPANY

RESOURCES

Downloads